MoPH okays Lilly’s oral GLP-1 treatment for obesity in Qatar
Have anything to say about this article?
You can report: fake news, misinformation, error, more information, additional data, etc.
CommentYour comment has been sent successfuly! Thank you.
MoPH okays Lilly’s oral GLP-1 treatment for obesity in Qatar
Tribune News Network Doha Eli Lilly’s once-daily oral GLP-1 receptor agonist for chronic weight management has been approved by Qatar’s Ministry of Public Health (MoPH), making it the first oral GLP-1 treatment approved for obesity in the country. Qatar is the sixth market globally to approve this »»»
QF’s QIYADA conference calls on Muslim youth to make goals and dreams their compass
Doha, Qatar: The importance of young Muslims finding and being guided by their “compass”, and using technology to drive positive change, has been emphasized by thought leaders as the second edition of Qatar Foundation’s QIYADA conference came to a close. The two-day gathering at Multaqa (Education »»»
Have anything to say about this article?
You can report: fake news, misinformation, error, more information, additional data, etc.
Comment